Cefditoren versus community-acquired respiratory pathogens: time-kill studies.

Area of Science:

• Microbiology
• Pharmacology
• Infectious Diseases

Background:

• Community-acquired respiratory tract infections (CARTIs) are common and require effective antibiotic treatment.
• Evaluating the bactericidal activity of newer antibiotics against prevalent pathogens is crucial for optimizing therapy.

Purpose of the Study:

• To compare the bactericidal activity of cefditoren with other oral antibiotics against common CARTI pathogens.
• To assess the time-kill kinetics of cefditoren.

Main Methods:

• The time-kill method was employed to evaluate bactericidal activity.
• Antibiotics tested included cefditoren, oral cephalosporins, amoxicillin, amoxicillin/clavulanate, and levofloxacin.
• Bacterial strains were isolated from patients with CARTIs.

Main Results:

• Cefditoren exhibited significant bactericidal activity within 4 hours against all tested Streptococcus pneumoniae strains (penicillin-susceptible and -resistant), Streptococcus pyogenes, and Moraxella catarrhalis.
• Against beta-lactamase positive Haemophilus influenzae, cefditoren showed activity comparable to levofloxacin and superior to other cephalosporins at 24 hours.
• Cefditoren displayed the most favorable killing kinetic profiles among the tested agents.

Conclusions:

• Cefditoren possesses potent and rapid bactericidal activity against key pathogens implicated in CARTIs.
• Its efficacy, particularly against resistant strains, suggests it is a valuable option for initial or sequential oral therapy.
• Cefditoren's pharmacokinetic profile supports its role in managing respiratory tract infections.